ATMIN: A New Tumor Suppressor in Developing B Cells

Slides:



Advertisements
Similar presentations
Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.
Advertisements

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Maintaining Cell Identity through Global Control of Genomic Organization Gioacchino Natoli Immunity Volume 33, Issue 1, Pages (July 2010) DOI: /j.immuni
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer Min Ni, Yiwen Chen, Elgene Lim, Hallie Wimberly, Shannon T. Bailey, Yuuki Imai,
C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells Roger R. Gomis, Claudio Alarcón, Cristina Nadal, Catherine.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
Nuclear Receptors, RXR, and the Big Bang Ronald M. Evans, David J. Mangelsdorf Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes Tae-Min Kim, Peter W. Laird, Peter J. Park Cell Volume 155, Issue.
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53- independent and mTORC1-dependent manner Jennifer E. Skeen, Prashanth.
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung Zvi Granot, Erik Henke, Elizabeth A. Comen, Tari A. King, Larry Norton, Robert Benezra.
DJ-1, a novel regulator of the tumor suppressor PTEN Raymond H. Kim, Malte Peters, YingJu Jang, Wei Shi, Melania Pintilie, Graham C. Fletcher, Carmela.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin Malay Haldar, Jeffrey D. Hancock, Cheryl M. Coffin, Stephen L. Lessnick,
Karl S. Peggs, Neil H. Segal, James P. Allison  Cancer Cell 
New Views into the Prostate Cancer Genome
Expanding the Biologist’s Toolkit with CRISPR-Cas9
Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension
“Ring-Fencing” BRCA1 Tumor Suppressor Activity
Wild-Type RAS: Keeping Mutant RAS in CHK
Metastasis gets site specific
The Ids Have It Cancer Cell
A Time to Divide: Does the Circadian Clock Control Cell Cycle?
Volume 11, Issue 4, Pages (April 2007)
A Mitochondrial Power Play in Lymphoma
Oh what a tangled web it weaves: BRCA1 and DNA decatenation
Actin and Microtubules: Working Together to Control Spindle Polarity
MDS Is a Stem Cell Disorder After All
DAISY: Picking Synthetic Lethals from Cancer Genomes
Volume 26, Issue 1, Pages 1-2 (July 2014)
A Radical Role for p38 MAPK in Tumor Initiation
Origin of Chromosomal Translocations in Lymphoid Cancer
Essential Role for Oxidative Phosphorylation in Cancer Progression
Cécile L. Maire, Keith L. Ligon  Cancer Cell 
Combinatorial Haplo-Deficient Tumor Suppression in 7q-Deficient Myelodysplastic Syndrome and Acute Myeloid Leukemia  Britta Will, Ulrich Steidl  Cancer.
Take care of your chromosomes lest cancer take care of you
Learning the ABCs of Melanoma-Initiating Cells
The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Epigenetics Drives RAGs to Recombination Riches
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy
Considering the critical interface between tumor cells and stromal cells in the search for targets for anticancer therapy  Laurence Blavier, Yves A. DeClerck 
An Integrin-Linked Machinery of Cytoskeletal Regulation that Enables Experimental Tumor Initiation and Metastatic Colonization  Tsukasa Shibue, Mary W.
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
LKB1 and Src: Antagonistic Regulators of Tumor Growth and Metastasis
Translocation Mapping Exposes the Risky Lifestyle of B Cells
Complicated Tails: Histone Modifications and the DNA Damage Response
Moving Right Along: How PP1 Helps Clear the Checkpoint
Volume 34, Issue 3, Pages (May 2009)
Mst Out and HCC In Cancer Cell
To Infinium, and Beyond! Cancer Cell
Padmanee Sharma, James P. Allison  Cell 
Volume 10, Issue 3, Pages (September 2006)
All Roads Lead to the Ribosome
Chapter 29 - Stem Cells and Generation of New Cells in the
Learning the ABCs of Melanoma-Initiating Cells
Epigenome Sequencing Comes of Age
There's a Time and a Place for MYCN
PP2A fulfills its promises as tumor suppressor
Gankyrin: An intriguing name for a novel regulator of p53 and RB
Structural basis of multimer-mediated mayhem
Ibrutinib Treatment of CLL: The Cancer Fights Back
Volume 12, Issue 6, Pages (December 2007)
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
The Ups and Downs of Src Regulation: Tumor Suppression by Cbp
Presentation transcript:

ATMIN: A New Tumor Suppressor in Developing B Cells Xiangyu Liu, Shan Zha  Cancer Cell  Volume 19, Issue 5, Pages 569-570 (May 2011) DOI: 10.1016/j.ccr.2011.05.002 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 ATMIN Is a Tumor Suppressor in Developing B Cells B cell development requires sequential modifications of the antigen-receptor loci through V(D)J recombination and CSR. Both V(D)J recombination and CSR generate DNA DSBs and involve chromatin changes, which activate ATM and lead to the phosphorylation of ATM substrates. ATMIN potentially contributes to DNA repair and checkpoint control in developing B cells (I) as an activator of ATM in response to chromatin changes, (II) as a substrate of ATM, and (III) as independent of ATM. Together, ATMIN deficiency leads to genomic instability and B cell lymphomas. Cancer Cell 2011 19, 569-570DOI: (10.1016/j.ccr.2011.05.002) Copyright © 2011 Elsevier Inc. Terms and Conditions